Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer
about
Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine.The pathophysiology and clinical aspects of hypercalcemic disorders.Hypercalcemia, pneumothorax and pneumoperitoneum in a patient with pulmonary mycobacteriosis and esophageal carcinoma.Tumour-associated hormonal products.Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism.Immunochemical localization of parathyroid hormone in cancer tissue from patients with ectopic hyperparathyroidism.Tumor hypercalcemia.Cell differentiation and the biological significance of inappropriate tumour productsParathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and reviewSubunits of human chorionic gonadotropin: unbalanced synthesis and secretion by clonal cell strains derived from a bronchogenic carcinoma.Lymphoma with hypercalcemiaCancer Diagnostics via Ultrasensitive Multiplexed Detection of Parathyroid Hormone-Related Peptides with a Microfluidic ImmunoarrayDifferential laboratory diagnosis of hypercalcemia.Parathyroid Hormone-Related Protein, Its Regulation of Cartilage and Bone Development, and Role in Treating Bone Diseases.The differentiation of primary hyperparathyroidism from the hypercalcemia of malignancy.Pharmacology and therapeutics of bone.Phaeochromocytoma and hypercalcaemia.Recognizing hyperparathyroidism caused by ectopic production of a substance resembling parathyroid hormone.Association of ectopically produced hyperparathyroidism with hepatoma.Synthetic analogue of bone mineral formation.
P2860
Q30416231-6DCB108B-FA2C-4E4B-AE1F-3B673C4EC5D1Q34052040-4E841C6C-90DF-46E3-BD4F-B073E3458383Q34108517-82F86F7A-BBDD-4F04-9A40-FC678AB4064FQ34303101-520CA339-7860-4CB0-8AB1-D61393E21C1AQ34463848-F63BF1E1-78D1-4A02-BB3C-1E953C6BD2DEQ34519667-9B48202E-FE05-4103-9CD6-A5FBCB04CC78Q34584287-A409C065-01A4-436F-82DC-DE150BDF14DFQ34983029-B3CF25DD-E8C8-4FCB-A073-DE13CC5AEDFCQ35063407-973CBD4D-CB55-4186-835E-CBDC52BDBD39Q35103632-9E72DFA0-AA13-483C-A552-DAA254F328B7Q35957165-ACC30C53-477A-4747-AB60-222D2D221A97Q37274228-06F7276F-039F-401B-8566-4EB0D77DAAA3Q38583499-DAC4E127-5959-438B-91E6-567394FCC2BAQ38824663-307E011D-FF65-4FED-B900-87F4C32091A8Q39589807-555FB690-AF68-43E7-9EFE-5A669EB77AA9Q39932991-3E02564A-6EE5-4CB2-8033-99D56F34F797Q41223279-BB577000-7395-4335-A45E-DF91B8684678Q41890156-1D50087E-080A-4A0C-A5AA-D55FF70FBD19Q42729179-1049AAAD-B978-4E3A-A985-CEE8FE87F839Q43501489-4BDB6833-72B7-40C9-8D32-CD792580E8EC
P2860
Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer
description
1971 nî lūn-bûn
@nan
1971 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1971 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1971年の論文
@ja
1971年論文
@yue
1971年論文
@zh-hant
1971年論文
@zh-hk
1971年論文
@zh-mo
1971年論文
@zh-tw
1971年论文
@wuu
name
Immunologic differentiation of ...... m due to nonparathyroid cancer
@ast
Immunologic differentiation of ...... m due to nonparathyroid cancer
@en
Immunologic differentiation of ...... m due to nonparathyroid cancer
@nl
type
label
Immunologic differentiation of ...... m due to nonparathyroid cancer
@ast
Immunologic differentiation of ...... m due to nonparathyroid cancer
@en
Immunologic differentiation of ...... m due to nonparathyroid cancer
@nl
prefLabel
Immunologic differentiation of ...... m due to nonparathyroid cancer
@ast
Immunologic differentiation of ...... m due to nonparathyroid cancer
@en
Immunologic differentiation of ...... m due to nonparathyroid cancer
@nl
P2093
P2860
P356
P1476
Immunologic differentiation of ...... m due to nonparathyroid cancer
@en
P2093
P2860
P304
P356
10.1172/JCI106701
P407
P577
1971-10-01T00:00:00Z